92 related articles for article (PubMed ID: 8736825)
41. Validation of a procedure to assess ASA-response in patients with decreased, initial TRAP induced aggregation.
Boeer K; Reinhöfer M; Lösche W
Platelets; 2010; 21(5):314-9. PubMed ID: 20438395
[TBL] [Abstract][Full Text] [Related]
42. Advanced glycation end products induce a prothrombotic phenotype in mice via interaction with platelet CD36.
Zhu W; Li W; Silverstein RL
Blood; 2012 Jun; 119(25):6136-44. PubMed ID: 22431576
[TBL] [Abstract][Full Text] [Related]
43. Inhibition of human platelet aggregation by eosinophils.
Maziero AM; Lorenzetti R; Donato JL; Lilla S; De Nucci G
Life Sci; 2013 Sep; 93(9-11):416-22. PubMed ID: 23871985
[TBL] [Abstract][Full Text] [Related]
44. A comparative study of the effects of local anaesthetics on platelet aggregation.
Gilani AH; Saeed SA
Biochem Soc Trans; 1990 Apr; 18(2):288-9. PubMed ID: 2116336
[No Abstract] [Full Text] [Related]
45. Platelet p24/CD9, a member of the tetraspanin family of proteins.
Jennings LK; Crossno JT; Fox CF; White MM; Green CA
Ann N Y Acad Sci; 1994 Apr; 714():175-84. PubMed ID: 8017766
[No Abstract] [Full Text] [Related]
46. Defective platelet response to arachidonic acid and thromboxane A(2) in subjects with Pl(A2) polymorphism of beta(3) subunit (glycoprotein IIIa).
Andrioli G; Minuz P; Solero P; Pincelli S; Ortolani R; Lussignoli S; Bellavite P
Br J Haematol; 2000 Sep; 110(4):911-8. PubMed ID: 11054082
[TBL] [Abstract][Full Text] [Related]
47. Role of platelet membrane glycoproteins Ib/IX and IIb/IIIa, and of platelet alpha-granule proteins in platelet aggregation induced by human osteosarcoma cells.
Clezardin P; Drouin J; Morel-Kopp MC; Hanss M; Kehrel B; Serre CM; Kaplan C; Delmas PD
Cancer Res; 1993 Oct; 53(19):4695-700. PubMed ID: 7691402
[TBL] [Abstract][Full Text] [Related]
48. Effect of 4-hydroxy-2,3-trans-nonenal on platelet function.
Selley ML; McGuiness JA; Jenkin LA; Bartlett MR; Ardlie NG
Thromb Haemost; 1988 Apr; 59(2):143-6. PubMed ID: 3133806
[TBL] [Abstract][Full Text] [Related]
49. Effects of diamide and iodoacetamide on the expression of the glycoprotein IIb/IIIa complex on blood platelets.
Johnston GI; Heptinstall S; Lösche W
Biochem Biophys Res Commun; 1985 Mar; 127(3):822-7. PubMed ID: 2580519
[TBL] [Abstract][Full Text] [Related]
50. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding.
Bin Z; Kun L
Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795
[TBL] [Abstract][Full Text] [Related]
51. [The antiaggregant action of 2-morpholino-5-(thienyl-2)-6-H-1,3,4-thiadiazine in in vitro and ex vivo experiments].
Logvinova IuS; Makarov VA; Chupakhin ON; Sidorova LP; Perova NM; Rusinov VL
Eksp Klin Farmakol; 2013; 76(2):13-6. PubMed ID: 23631277
[TBL] [Abstract][Full Text] [Related]
52. Sulphonylurea agents inhibit platelet aggregation and [Ca2+]i elevation induced by arachidonic acid.
Qi R; Ozaki Y; Satoh K; Kurota K; Asazuma N; Yatomi Y; Kume S
Biochem Pharmacol; 1995 Jun; 49(12):1735-9. PubMed ID: 7598735
[TBL] [Abstract][Full Text] [Related]
53. Mechanisms of the priming effect of low doses of lipopoly-saccharides on leukocyte-dependent platelet aggregation in whole blood.
Montrucchio G; Bosco O; Del Sorbo L; Fascio Pecetto P; Lupia E; Goffi A; Omedè P; Emanuelli G; Camussi G
Thromb Haemost; 2003 Nov; 90(5):872-81. PubMed ID: 14597983
[TBL] [Abstract][Full Text] [Related]
54. The platelet antigens CD9, CD42 and integrin alpha IIb beta IIIa can be topographically associated and transduce functionally similar signals.
Slupsky JR; Kamiguti AS; Rhodes NP; Cawley JC; Shaw AR; Zuzel M
Eur J Biochem; 1997 Feb; 244(1):168-75. PubMed ID: 9063461
[TBL] [Abstract][Full Text] [Related]
55. Platelet pro-aggregatory effects of CD40L monoclonal antibody.
Mirabet M; Barrabés JA; Quiroga A; Garcia-Dorado D
Mol Immunol; 2008 Feb; 45(4):937-44. PubMed ID: 17959249
[TBL] [Abstract][Full Text] [Related]
56. Diagnosis of Glanzmann thrombasthenia by whole blood impedance analyzer (MEA) vs. light transmission aggregometry.
Albanyan A; Al-Musa A; AlNounou R; Al Zahrani H; Nasr R; AlJefri A; Saleh M; Malik A; Masmali H; Owaidah T
Int J Lab Hematol; 2015 Aug; 37(4):503-8. PubMed ID: 25537026
[TBL] [Abstract][Full Text] [Related]
57. Both CD62 and CD162 antibodies prevent formation of CD36-dependent platelets, rosettes, and artefactual pseudoexpression of platelet markers on white blood cells: a study with ImageStream®.
Ouk C; Jayat-Vignoles C; Donnard M; Feuillard J
Cytometry A; 2011 Jun; 79(6):477-84. PubMed ID: 21462306
[TBL] [Abstract][Full Text] [Related]
58. Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation--role of arachidonic acid metabolism.
Caccese D; Praticò D; Ghiselli A; Natoli S; Pignatelli P; Sanguigni V; Iuliano L; Violi F
Thromb Haemost; 2000 Mar; 83(3):485-90. PubMed ID: 10744158
[TBL] [Abstract][Full Text] [Related]
59. Differential effects of anti-asthmatic drugs on arachidonic acid and platelet-activating factor.
Saeed SA; Ali N; Saleem S
Biochem Soc Trans; 1994 Nov; 22(4):443S. PubMed ID: 7698461
[No Abstract] [Full Text] [Related]
60. CD36-mediated endocytic uptake of advanced glycation end products (AGE) in mouse 3T3-L1 and human subcutaneous adipocytes.
Kuniyasu A; Ohgami N; Hayashi S; Miyazaki A; Horiuchi S; Nakayama H
FEBS Lett; 2003 Feb; 537(1-3):85-90. PubMed ID: 12606036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
